We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters.
- Authors
Wei-Choong Ch'ng; Stanbridge, Eric J.; Kum-Thong Wong; Kien-Chai Ong; Yusoff, Khatijah; Shafee, Norazizah
- Abstract
Enterovirus 71 (EV71) causes severe neurological diseases resulting in high mortality in young children worldwide. Development of an effective vaccine against EV71 infection is hampered by the lack of appropriate animal models for efficacy testing of candidate vaccines. Previously, we have successfully tested the immunogenicity and protectiveness of a candidate EV71 vaccine, containing recombinant Newcastle disease virus capsids that display an EV71 VP1 fragment (NPt-VP11-100) protein, in a mouse model of EV71 infection. A drawback of this system is its limited window of EV71 susceptibility period, 2 weeks after birth, leading to restricted options in the evaluation of optimal dosing regimens. To address this issue, we have assessed the NPt-VP11-100 candidate vaccine in a hamster system, which offers a 4-week susceptibility period to EV71 infection. Results obtained showed that the NPt-VP11-100 candidate vaccine stimulated excellent humoral immune response in the hamsters. Despite the high level of antibody production, they failed to neutralize EV71 viruses or protect vaccinated hamsters in viral challenge studies. Nevertheless, these findings have contributed towards a better understanding of the NPt-VP11-100 recombinant protein as a candidate vaccine in an alternative animal model system.
- Subjects
IMMUNIZATION; CHILDREN'S health; ANIMAL models in research; PARAMYXOVIRUSES; IMMUNE response
- Publication
Virology Journal, 2012, Vol 9, Issue 1, p155
- ISSN
1743-422X
- Publication type
Article
- DOI
10.1186/1743-422X-9-155